Targeting integrins for cancer management using nanotherapeutic approaches: Recent advances and challenges

Khurshid Ahmad1, Eun Ju Lee1, Sibhghatulla Shaikh1

  • 1Department of Medical Biotechnology, Yeungnam University, Gyeongsan 38541, Republic of Korea.

Insights

Integrins, crucial cell receptors, drive cancer progression and metastasis. Nanotechnology offers promising targeted therapies, but challenges in nano-bio interactions and clinical trials remain for effective cancer management.

Area of Science:

  • Cell biology
  • Oncology
  • Nanomedicine

Background:

  • Integrins are vital cell surface receptors mediating cell-environment communication and signal transduction.
  • Altered integrin expression is common in cancers, implicating them in tumor formation and metastasis.
  • Conventional cancer therapies face limitations, driving the need for advanced treatment modalities.

Purpose of the Study:

  • To review the multifaceted roles of integrins and integrin-dependent signaling in various cancers.
  • To explore the application of nanotherapeutics targeting integrins for cancer management.
  • To discuss RGD-based strategies and associated challenges in cancer therapy.

Main Methods:

  • Literature review focusing on integrin function in cancer.
  • Analysis of nanotherapeutic strategies targeting integrins.
  • Discussion of RGD peptide applications and clinical trial hurdles.

Main Results:

  • Integrins play critical roles in cancer initiation, progression, and metastasis.
  • Nanotherapeutics targeting integrins demonstrate precision, safety, and efficacy in preclinical studies.
  • RGD-based approaches show potential but require further investigation for clinical translation.

Conclusions:

  • Integrin-targeted nanomedicine presents a promising avenue for improved cancer treatment.
  • Further research into nano-bio interactions and clinical trial design is essential for successful implementation.
  • Addressing current challenges will enhance the therapeutic potential of integrin-targeting nanotherapeutics in oncology.

Related Concept Videos

Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
5.3K
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques01:30

Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques

Airway management is essential in emergency and surgical medicine, ensuring ventilation and oxygenation in patients who cannot maintain their own airway. Clinicians use a range of techniques and devices to secure the airway, depending on the patient’s condition and the clinical context. Key methods include endotracheal intubation, rapid sequence intubation (RSI), supraglottic airway devices, and advanced visualization aids. In cases where these approaches fail, surgical airway...
488
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
5.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Extraction: Advanced Methods00:56

Extraction: Advanced Methods

Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.1K
Overview of Advanced Functional Groups02:22

Overview of Advanced Functional Groups


Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
29.2K